The global market for Capillary Blood Lancing Device was valued at US$ 458 million in the year 2024 and is projected to reach a revised size of US$ 643 million by 2031, growing at a CAGR of 5.0% during the forecast period.

Capillary Blood Lancing Device Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Capillary Blood Lancing Device competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

A Capillary Blood Lancing Device is a medical instrument designed to obtain small blood samples from peripheral capillaries—typically from the fingertip, earlobe, or heel—for use in blood glucose monitoring, lactate measurement, hemoglobin testing, and various point-of-care testing (POCT) applications. The device operates through a mechanical or spring-based puncture mechanism that delivers rapid, controlled skin penetration to ensure sufficient and consistent blood volume while minimizing pain and tissue trauma. Modern devices generally consist of a lancet, trigger mechanism, safety guard, and ergonomic housing, and are classified as either reusable or single-use depending on the clinical context. With the expansion of chronic disease self-management, home healthcare, and tiered medical systems, capillary blood lancing devices have evolved toward safer, low-pain, and digitally integrated designs, becoming an essential component within clinical diagnostics, personal health monitoring, and mobile healthcare ecosystems.In 2024, global Capillary Blood Lancing Device production reached approximately 57.21 m units, with an average global market price of around US$ 8 perunit.The average gross profit margin of this product is 45%.

The capillary blood lancing device market is undergoing a critical transformation from traditional consumables to intelligent and safety-focused solutions. The growing prevalence of diabetes and metabolic disorders drives strong demand for home blood glucose and multi-parameter testing. Healthcare reforms emphasizing primary care and telemedicine have made portable, safe, and easy-to-use devices essential for community and home applications. Meanwhile, the integration of POCT and digital health platforms is accelerating, encouraging manufacturers to connect lancing devices with analyzers, mobile apps, and cloud systems for seamless data transmission and health management. Corporate reports and government policies highlight that innovative products emphasizing safety protection, low-pain performance, and digital compatibility gain stronger market and regulatory acceptance.

Despite its growth potential, the industry faces mounting regulatory and competitive pressures. Stricter certification requirements for single-use needlestick devices—covering sterilization, safety retraction, and labeling—demand sustained R&D investment. Simultaneously, low-cost competitors are intensifying price wars, compressing margins for mid- and high-end brands. Fluctuations in the prices of medical-grade polycarbonate (PC), stainless-steel cannulas, and silicone components also challenge production economics. Company disclosures note that automation investment, intellectual property protection, and lengthy international approvals are major barriers for new entrants.

Downstream demand is increasingly segmented. Home users prioritize comfort, noise reduction, and pain minimization—driving rapid adoption of low-pain and child-specific products. Hospitals and laboratories favor retractable and single-use safety lancets to comply with infection-control standards. In sports and wellness testing, portable, fast, and analyzer-compatible devices are becoming mainstream. Brokerage and industry analyses indicate that lancing devices with strong interoperability and POCT compatibility will emerge as key entry products in the digital health ecosystem.

The main materials for capillary blood lancing devices include medical-grade stainless-steel needles, polypropylene (PP), polycarbonate (PC), medical silicone, precision springs, and lubricative coatings. Upstream suppliers must comply with ISO 13485 quality systems and biocompatibility standards to ensure puncture precision and consistency. The sector is trending toward biodegradable materials and green manufacturing to align with sustainability policies. Additionally, high-precision mold design and automated assembly are becoming decisive factors for yield and consistency. In sum, material innovation and supply chain stability have become core competitive differentiators for leading players.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Capillary Blood Lancing Device, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Capillary Blood Lancing Device.

The Capillary Blood Lancing Device market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Capillary Blood Lancing Device market comprehensively. Regional market sizes, concerning products by Type, by Application, by Operation and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Capillary Blood Lancing Device manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, by Operation and by regions.

Scope of Capillary Blood Lancing Device Market Report

Report Metric	Details
Report Name	Capillary Blood Lancing Device Market
Accounted market size in year	US$ 458 million
Forecasted market size in 2031	US$ 643 million
CAGR	5.0%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Adjustable Lancing Device Non-adjustable Lancing Device
Segment by Operation	Manual Lancing Pen Automatic Lancing Pen
Segment by Protection Mechanisms	Standard Pen Safety Lancing Pen
Segment by Application	Hospital Clinic Homecare Other
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Roche, Lifescan, Abbott, Ascensia, B. Braun, TERUMO, Sinocare, ARKRAY, GMMC Group, BIONIME, LIANFA, Lobeck Medical AG
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Capillary Blood Lancing Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Capillary Blood Lancing Device in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Capillary Blood Lancing Device Market growing?

Ans: The Capillary Blood Lancing Device Market witnessing a CAGR of 5.0% during the forecast period 2025-2031.

What is the Capillary Blood Lancing Device Market size in 2031?

Ans: The Capillary Blood Lancing Device Market size in 2031 will be US$ 643 million.

Who are the main players in the Capillary Blood Lancing Device Market report?

Ans: The main players in the Capillary Blood Lancing Device Market are Roche, Lifescan, Abbott, Ascensia, B. Braun, TERUMO, Sinocare, ARKRAY, GMMC Group, BIONIME, LIANFA, Lobeck Medical AG

What are the Application segmentation covered in the Capillary Blood Lancing Device Market report?

Ans: The Applications covered in the Capillary Blood Lancing Device Market report are Hospital, Clinic, Homecare, Other

What are the Type segmentation covered in the Capillary Blood Lancing Device Market report?

Ans: The Types covered in the Capillary Blood Lancing Device Market report are Adjustable Lancing Device, Non-adjustable Lancing Device

1 Capillary Blood Lancing Device Market Overview

1.1 Product Definition

1.2 Capillary Blood Lancing Device by Type

1.2.1 Global Capillary Blood Lancing Device Market Value Comparison by Type (2024 VS 2031)

1.2.2 Adjustable Lancing Device

1.2.3 Non-adjustable Lancing Device

1.3 Capillary Blood Lancing Device by Operation

1.3.1 Global Capillary Blood Lancing Device Market Value Comparison by Operation: 2024 VS 2031

1.3.2 Manual Lancing Pen

1.3.3 Automatic Lancing Pen

1.4 Capillary Blood Lancing Device by Protection Mechanisms

1.4.1 Global Capillary Blood Lancing Device Market Value Comparison by Protection Mechanisms: 2024 VS 2031

1.4.2 Standard Pen

1.4.3 Safety Lancing Pen

1.5 Capillary Blood Lancing Device by Application

1.5.1 Global Capillary Blood Lancing Device Market Value by Application (2024 VS 2031)

1.5.2 Hospital

1.5.3 Clinic

1.5.4 Homecare

1.5.5 Other

1.6 Global Capillary Blood Lancing Device Market Size Estimates and Forecasts

1.6.1 Global Capillary Blood Lancing Device Revenue 2020-2031

1.6.2 Global Capillary Blood Lancing Device Sales 2020-2031

1.6.3 Global Capillary Blood Lancing Device Market Average Price (2020-2031)

1.7 Assumptions and Limitations

2 Capillary Blood Lancing Device Market Competition by Manufacturers

2.1 Global Capillary Blood Lancing Device Sales Market Share by Manufacturers (2020-2025)

2.2 Global Capillary Blood Lancing Device Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Capillary Blood Lancing Device Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Capillary Blood Lancing Device, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Capillary Blood Lancing Device, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Capillary Blood Lancing Device, Product Type & Application

2.7 Global Key Manufacturers of Capillary Blood Lancing Device, Date of Enter into This Industry

2.8 Global Capillary Blood Lancing Device Market Competitive Situation and Trends

2.8.1 Global Capillary Blood Lancing Device Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Capillary Blood Lancing Device Players Market Share by Revenue

2.8.3 Global Capillary Blood Lancing Device Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Capillary Blood Lancing Device Market Scenario by Region

3.1 Global Capillary Blood Lancing Device Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Capillary Blood Lancing Device Sales by Region: 2020-2031

3.2.1 Global Capillary Blood Lancing Device Sales by Region: 2020-2025

3.2.2 Global Capillary Blood Lancing Device Sales by Region: 2026-2031

3.3 Global Capillary Blood Lancing Device Revenue by Region: 2020-2031

3.3.1 Global Capillary Blood Lancing Device Revenue by Region: 2020-2025

3.3.2 Global Capillary Blood Lancing Device Revenue by Region: 2026-2031

3.4 North America Capillary Blood Lancing Device Market Facts & Figures by Country

3.4.1 North America Capillary Blood Lancing Device Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Capillary Blood Lancing Device Sales by Country (2020-2031)

3.4.3 North America Capillary Blood Lancing Device Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Capillary Blood Lancing Device Market Facts & Figures by Country

3.5.1 Europe Capillary Blood Lancing Device Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Capillary Blood Lancing Device Sales by Country (2020-2031)

3.5.3 Europe Capillary Blood Lancing Device Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Capillary Blood Lancing Device Market Facts & Figures by Region

3.6.1 Asia Pacific Capillary Blood Lancing Device Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Capillary Blood Lancing Device Sales by Region (2020-2031)

3.6.3 Asia Pacific Capillary Blood Lancing Device Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Capillary Blood Lancing Device Market Facts & Figures by Country

3.7.1 Latin America Capillary Blood Lancing Device Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Capillary Blood Lancing Device Sales by Country (2020-2031)

3.7.3 Latin America Capillary Blood Lancing Device Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Capillary Blood Lancing Device Market Facts & Figures by Country

3.8.1 Middle East and Africa Capillary Blood Lancing Device Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Capillary Blood Lancing Device Sales by Country (2020-2031)

3.8.3 Middle East and Africa Capillary Blood Lancing Device Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Capillary Blood Lancing Device Sales by Type (2020-2031)

4.1.1 Global Capillary Blood Lancing Device Sales by Type (2020-2025)

4.1.2 Global Capillary Blood Lancing Device Sales by Type (2026-2031)

4.1.3 Global Capillary Blood Lancing Device Sales Market Share by Type (2020-2031)

4.2 Global Capillary Blood Lancing Device Revenue by Type (2020-2031)

4.2.1 Global Capillary Blood Lancing Device Revenue by Type (2020-2025)

4.2.2 Global Capillary Blood Lancing Device Revenue by Type (2026-2031)

4.2.3 Global Capillary Blood Lancing Device Revenue Market Share by Type (2020-2031)

4.3 Global Capillary Blood Lancing Device Price by Type (2020-2031)

5 Segment by Application

5.1 Global Capillary Blood Lancing Device Sales by Application (2020-2031)

5.1.1 Global Capillary Blood Lancing Device Sales by Application (2020-2025)

5.1.2 Global Capillary Blood Lancing Device Sales by Application (2026-2031)

5.1.3 Global Capillary Blood Lancing Device Sales Market Share by Application (2020-2031)

5.2 Global Capillary Blood Lancing Device Revenue by Application (2020-2031)

5.2.1 Global Capillary Blood Lancing Device Revenue by Application (2020-2025)

5.2.2 Global Capillary Blood Lancing Device Revenue by Application (2026-2031)

5.2.3 Global Capillary Blood Lancing Device Revenue Market Share by Application (2020-2031)

5.3 Global Capillary Blood Lancing Device Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Roche

6.1.1 Roche Company Information

6.1.2 Roche Description and Business Overview

6.1.3 Roche Capillary Blood Lancing Device Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Roche Capillary Blood Lancing Device Product Portfolio

6.1.5 Roche Recent Developments/Updates

6.2 Lifescan

6.2.1 Lifescan Company Information

6.2.2 Lifescan Description and Business Overview

6.2.3 Lifescan Capillary Blood Lancing Device Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Lifescan Capillary Blood Lancing Device Product Portfolio

6.2.5 Lifescan Recent Developments/Updates

6.3 Abbott

6.3.1 Abbott Company Information

6.3.2 Abbott Description and Business Overview

6.3.3 Abbott Capillary Blood Lancing Device Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Abbott Capillary Blood Lancing Device Product Portfolio

6.3.5 Abbott Recent Developments/Updates

6.4 Ascensia

6.4.1 Ascensia Company Information

6.4.2 Ascensia Description and Business Overview

6.4.3 Ascensia Capillary Blood Lancing Device Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Ascensia Capillary Blood Lancing Device Product Portfolio

6.4.5 Ascensia Recent Developments/Updates

6.5 B. Braun

6.5.1 B. Braun Company Information

6.5.2 B. Braun Description and Business Overview

6.5.3 B. Braun Capillary Blood Lancing Device Sales, Revenue and Gross Margin (2020-2025)

6.5.4 B. Braun Capillary Blood Lancing Device Product Portfolio

6.5.5 B. Braun Recent Developments/Updates

6.6 TERUMO

6.6.1 TERUMO Company Information

6.6.2 TERUMO Description and Business Overview

6.6.3 TERUMO Capillary Blood Lancing Device Sales, Revenue and Gross Margin (2020-2025)

6.6.4 TERUMO Capillary Blood Lancing Device Product Portfolio

6.6.5 TERUMO Recent Developments/Updates

6.7 Sinocare

6.7.1 Sinocare Company Information

6.7.2 Sinocare Description and Business Overview

6.7.3 Sinocare Capillary Blood Lancing Device Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Sinocare Capillary Blood Lancing Device Product Portfolio

6.7.5 Sinocare Recent Developments/Updates

6.8 ARKRAY

6.8.1 ARKRAY Company Information

6.8.2 ARKRAY Description and Business Overview

6.8.3 ARKRAY Capillary Blood Lancing Device Sales, Revenue and Gross Margin (2020-2025)

6.8.4 ARKRAY Capillary Blood Lancing Device Product Portfolio

6.8.5 ARKRAY Recent Developments/Updates

6.9 GMMC Group

6.9.1 GMMC Group Company Information

6.9.2 GMMC Group Description and Business Overview

6.9.3 GMMC Group Capillary Blood Lancing Device Sales, Revenue and Gross Margin (2020-2025)

6.9.4 GMMC Group Capillary Blood Lancing Device Product Portfolio

6.9.5 GMMC Group Recent Developments/Updates

6.10 BIONIME

6.10.1 BIONIME Company Information

6.10.2 BIONIME Description and Business Overview

6.10.3 BIONIME Capillary Blood Lancing Device Sales, Revenue and Gross Margin (2020-2025)

6.10.4 BIONIME Capillary Blood Lancing Device Product Portfolio

6.10.5 BIONIME Recent Developments/Updates

6.11 LIANFA

6.11.1 LIANFA Company Information

6.11.2 LIANFA Description and Business Overview

6.11.3 LIANFA Capillary Blood Lancing Device Sales, Revenue and Gross Margin (2020-2025)

6.11.4 LIANFA Capillary Blood Lancing Device Product Portfolio

6.11.5 LIANFA Recent Developments/Updates

6.12 Lobeck Medical AG

6.12.1 Lobeck Medical AG Company Information

6.12.2 Lobeck Medical AG Description and Business Overview

6.12.3 Lobeck Medical AG Capillary Blood Lancing Device Sales, Revenue and Gross Margin (2020-2025)

6.12.4 Lobeck Medical AG Capillary Blood Lancing Device Product Portfolio

6.12.5 Lobeck Medical AG Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Capillary Blood Lancing Device Industry Chain Analysis

7.2 Capillary Blood Lancing Device Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Capillary Blood Lancing Device Production Mode & Process Analysis

7.4 Capillary Blood Lancing Device Sales and Marketing

7.4.1 Capillary Blood Lancing Device Sales Channels

7.4.2 Capillary Blood Lancing Device Distributors

7.5 Capillary Blood Lancing Device Customer Analysis

8 Capillary Blood Lancing Device Market Dynamics

8.1 Capillary Blood Lancing Device Industry Trends

8.2 Capillary Blood Lancing Device Market Drivers

8.3 Capillary Blood Lancing Device Market Challenges

8.4 Capillary Blood Lancing Device Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Capillary Blood Lancing Device Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Capillary Blood Lancing Device Market Value by Operation, (US$ Million) & (2024 VS 2031)

Table 3. Global Capillary Blood Lancing Device Market Value by Protection Mechanisms, (US$ Million) & (2024 VS 2031)

Table 4. Global Capillary Blood Lancing Device Market Value by Application (2024 VS 2031) & (US$ Million)

Table 5. Global Capillary Blood Lancing Device Market Competitive Situation by Manufacturers in 2024

Table 6. Global Capillary Blood Lancing Device Sales (K Units) of Key Manufacturers (2020-2025)

Table 7. Global Capillary Blood Lancing Device Sales Market Share by Manufacturers (2020-2025)

Table 8. Global Capillary Blood Lancing Device Revenue (US$ Million) by Manufacturers (2020-2025)

Table 9. Global Capillary Blood Lancing Device Revenue Share by Manufacturers (2020-2025)

Table 10. Global Market Capillary Blood Lancing Device Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 11. Global Key Players of Capillary Blood Lancing Device, Industry Ranking, 2022 VS 2023 VS 2024

Table 12. Global Key Manufacturers of Capillary Blood Lancing Device, Manufacturing Sites & Headquarters

Table 13. Global Key Manufacturers of Capillary Blood Lancing Device, Product Type & Application

Table 14. Global Key Manufacturers of Capillary Blood Lancing Device, Date of Enter into This Industry

Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 16. Global Capillary Blood Lancing Device by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Capillary Blood Lancing Device as of 2024)

Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 18. Global Capillary Blood Lancing Device Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 19. Global Capillary Blood Lancing Device Sales by Region (2020-2025) & (K Units)

Table 20. Global Capillary Blood Lancing Device Sales Market Share by Region (2020-2025)

Table 21. Global Capillary Blood Lancing Device Sales by Region (2026-2031) & (K Units)

Table 22. Global Capillary Blood Lancing Device Sales Market Share by Region (2026-2031)

Table 23. Global Capillary Blood Lancing Device Revenue by Region (2020-2025) & (US$ Million)

Table 24. Global Capillary Blood Lancing Device Revenue Market Share by Region (2020-2025)

Table 25. Global Capillary Blood Lancing Device Revenue by Region (2026-2031) & (US$ Million)

Table 26. Global Capillary Blood Lancing Device Revenue Market Share by Region (2026-2031)

Table 27. North America Capillary Blood Lancing Device Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 28. North America Capillary Blood Lancing Device Sales by Country (2020-2025) & (K Units)

Table 29. North America Capillary Blood Lancing Device Sales by Country (2026-2031) & (K Units)

Table 30. North America Capillary Blood Lancing Device Revenue by Country (2020-2025) & (US$ Million)

Table 31. North America Capillary Blood Lancing Device Revenue by Country (2026-2031) & (US$ Million)

Table 32. Europe Capillary Blood Lancing Device Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 33. Europe Capillary Blood Lancing Device Sales by Country (2020-2025) & (K Units)

Table 34. Europe Capillary Blood Lancing Device Sales by Country (2026-2031) & (K Units)

Table 35. Europe Capillary Blood Lancing Device Revenue by Country (2020-2025) & (US$ Million)

Table 36. Europe Capillary Blood Lancing Device Revenue by Country (2026-2031) & (US$ Million)

Table 37. Asia Pacific Capillary Blood Lancing Device Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 38. Asia Pacific Capillary Blood Lancing Device Sales by Region (2020-2025) & (K Units)

Table 39. Asia Pacific Capillary Blood Lancing Device Sales by Region (2026-2031) & (K Units)

Table 40. Asia Pacific Capillary Blood Lancing Device Revenue by Region (2020-2025) & (US$ Million)

Table 41. Asia Pacific Capillary Blood Lancing Device Revenue by Region (2026-2031) & (US$ Million)

Table 42. Latin America Capillary Blood Lancing Device Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 43. Latin America Capillary Blood Lancing Device Sales by Country (2020-2025) & (K Units)

Table 44. Latin America Capillary Blood Lancing Device Sales by Country (2026-2031) & (K Units)

Table 45. Latin America Capillary Blood Lancing Device Revenue by Country (2020-2025) & (US$ Million)

Table 46. Latin America Capillary Blood Lancing Device Revenue by Country (2026-2031) & (US$ Million)

Table 47. Middle East and Africa Capillary Blood Lancing Device Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 48. Middle East and Africa Capillary Blood Lancing Device Sales by Country (2020-2025) & (K Units)

Table 49. Middle East and Africa Capillary Blood Lancing Device Sales by Country (2026-2031) & (K Units)

Table 50. Middle East and Africa Capillary Blood Lancing Device Revenue by Country (2020-2025) & (US$ Million)

Table 51. Middle East and Africa Capillary Blood Lancing Device Revenue by Country (2026-2031) & (US$ Million)

Table 52. Global Capillary Blood Lancing Device Sales (K Units) by Type (2020-2025)

Table 53. Global Capillary Blood Lancing Device Sales (K Units) by Type (2026-2031)

Table 54. Global Capillary Blood Lancing Device Sales Market Share by Type (2020-2025)

Table 55. Global Capillary Blood Lancing Device Sales Market Share by Type (2026-2031)

Table 56. Global Capillary Blood Lancing Device Revenue (US$ Million) by Type (2020-2025)

Table 57. Global Capillary Blood Lancing Device Revenue (US$ Million) by Type (2026-2031)

Table 58. Global Capillary Blood Lancing Device Revenue Market Share by Type (2020-2025)

Table 59. Global Capillary Blood Lancing Device Revenue Market Share by Type (2026-2031)

Table 60. Global Capillary Blood Lancing Device Price (US$/Unit) by Type (2020-2025)

Table 61. Global Capillary Blood Lancing Device Price (US$/Unit) by Type (2026-2031)

Table 62. Global Capillary Blood Lancing Device Sales (K Units) by Application (2020-2025)

Table 63. Global Capillary Blood Lancing Device Sales (K Units) by Application (2026-2031)

Table 64. Global Capillary Blood Lancing Device Sales Market Share by Application (2020-2025)

Table 65. Global Capillary Blood Lancing Device Sales Market Share by Application (2026-2031)

Table 66. Global Capillary Blood Lancing Device Revenue (US$ Million) by Application (2020-2025)

Table 67. Global Capillary Blood Lancing Device Revenue (US$ Million) by Application (2026-2031)

Table 68. Global Capillary Blood Lancing Device Revenue Market Share by Application (2020-2025)

Table 69. Global Capillary Blood Lancing Device Revenue Market Share by Application (2026-2031)

Table 70. Global Capillary Blood Lancing Device Price (US$/Unit) by Application (2020-2025)

Table 71. Global Capillary Blood Lancing Device Price (US$/Unit) by Application (2026-2031)

Table 72. Roche Company Information

Table 73. Roche Description and Business Overview

Table 74. Roche Capillary Blood Lancing Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 75. Roche Capillary Blood Lancing Device Product

Table 76. Roche Recent Developments/Updates

Table 77. Lifescan Company Information

Table 78. Lifescan Description and Business Overview

Table 79. Lifescan Capillary Blood Lancing Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 80. Lifescan Capillary Blood Lancing Device Product

Table 81. Lifescan Recent Developments/Updates

Table 82. Abbott Company Information

Table 83. Abbott Description and Business Overview

Table 84. Abbott Capillary Blood Lancing Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 85. Abbott Capillary Blood Lancing Device Product

Table 86. Abbott Recent Developments/Updates

Table 87. Ascensia Company Information

Table 88. Ascensia Description and Business Overview

Table 89. Ascensia Capillary Blood Lancing Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 90. Ascensia Capillary Blood Lancing Device Product

Table 91. Ascensia Recent Developments/Updates

Table 92. B. Braun Company Information

Table 93. B. Braun Description and Business Overview

Table 94. B. Braun Capillary Blood Lancing Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 95. B. Braun Capillary Blood Lancing Device Product

Table 96. B. Braun Recent Developments/Updates

Table 97. TERUMO Company Information

Table 98. TERUMO Description and Business Overview

Table 99. TERUMO Capillary Blood Lancing Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 100. TERUMO Capillary Blood Lancing Device Product

Table 101. TERUMO Recent Developments/Updates

Table 102. Sinocare Company Information

Table 103. Sinocare Description and Business Overview

Table 104. Sinocare Capillary Blood Lancing Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 105. Sinocare Capillary Blood Lancing Device Product

Table 106. Sinocare Recent Developments/Updates

Table 107. ARKRAY Company Information

Table 108. ARKRAY Description and Business Overview

Table 109. ARKRAY Capillary Blood Lancing Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 110. ARKRAY Capillary Blood Lancing Device Product

Table 111. ARKRAY Recent Developments/Updates

Table 112. GMMC Group Company Information

Table 113. GMMC Group Description and Business Overview

Table 114. GMMC Group Capillary Blood Lancing Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 115. GMMC Group Capillary Blood Lancing Device Product

Table 116. GMMC Group Recent Developments/Updates

Table 117. BIONIME Company Information

Table 118. BIONIME Description and Business Overview

Table 119. BIONIME Capillary Blood Lancing Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 120. BIONIME Capillary Blood Lancing Device Product

Table 121. BIONIME Recent Developments/Updates

Table 122. LIANFA Company Information

Table 123. LIANFA Description and Business Overview

Table 124. LIANFA Capillary Blood Lancing Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 125. LIANFA Capillary Blood Lancing Device Product

Table 126. LIANFA Recent Developments/Updates

Table 127. Lobeck Medical AG Company Information

Table 128. Lobeck Medical AG Description and Business Overview

Table 129. Lobeck Medical AG Capillary Blood Lancing Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 130. Lobeck Medical AG Capillary Blood Lancing Device Product

Table 131. Lobeck Medical AG Recent Developments/Updates

Table 132. Key Raw Materials Lists

Table 133. Raw Materials Key Suppliers Lists

Table 134. Capillary Blood Lancing Device Distributors List

Table 135. Capillary Blood Lancing Device Customers List

Table 136. Capillary Blood Lancing Device Market Trends

Table 137. Capillary Blood Lancing Device Market Drivers

Table 138. Capillary Blood Lancing Device Market Challenges

Table 139. Capillary Blood Lancing Device Market Restraints

Table 140. Research Programs/Design for This Report

Table 141. Key Data Information from Secondary Sources

Table 142. Key Data Information from Primary Sources

Table 143. Authors List of This Report

List of Figures

Figure 1. Product Picture of Capillary Blood Lancing Device

Figure 2. Global Capillary Blood Lancing Device Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Capillary Blood Lancing Device Market Share by Type: 2024 & 2031

Figure 4. Adjustable Lancing Device Product Picture

Figure 5. Non-adjustable Lancing Device Product Picture

Figure 6. Global Capillary Blood Lancing Device Market Value by Operation, (US$ Million) & (2020-2031)

Figure 7. Global Capillary Blood Lancing Device Market Share by Operation: 2024 VS 2031

Figure 8. Manual Lancing Pen Product Picture

Figure 9. Automatic Lancing Pen Product Picture

Figure 10. Global Capillary Blood Lancing Device Market Value by Protection Mechanisms, (US$ Million) & (2020-2031)

Figure 11. Global Capillary Blood Lancing Device Market Share by Protection Mechanisms: 2024 VS 2031

Figure 12. Standard Pen Product Picture

Figure 13. Safety Lancing Pen Product Picture

Figure 14. Global Capillary Blood Lancing Device Market Value by Application (2020-2031) & (US$ Million)

Figure 15. Global Capillary Blood Lancing Device Market Share by Application: 2024 & 2031

Figure 16. Hospital

Figure 17. Clinic

Figure 18. Homecare

Figure 19. Other

Figure 20. Global Capillary Blood Lancing Device Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 21. Global Capillary Blood Lancing Device Market Size (2020-2031) & (US$ Million)

Figure 22. Global Capillary Blood Lancing Device Sales (2020-2031) & (K Units)

Figure 23. Global Capillary Blood Lancing Device Average Price (US$/Unit) & (2020-2031)

Figure 24. Capillary Blood Lancing Device Report Years Considered

Figure 25. Capillary Blood Lancing Device Sales Share by Manufacturers in 2024

Figure 26. Global Capillary Blood Lancing Device Revenue Share by Manufacturers in 2024

Figure 27. Global 5 and 10 Largest Capillary Blood Lancing Device Players: Market Share by Revenue in Capillary Blood Lancing Device in 2024

Figure 28. Capillary Blood Lancing Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 29. Global Capillary Blood Lancing Device Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 30. North America Capillary Blood Lancing Device Sales Market Share by Country (2020-2031)

Figure 31. North America Capillary Blood Lancing Device Revenue Market Share by Country (2020-2031)

Figure 32. United States Capillary Blood Lancing Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Canada Capillary Blood Lancing Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. Europe Capillary Blood Lancing Device Sales Market Share by Country (2020-2031)

Figure 35. Europe Capillary Blood Lancing Device Revenue Market Share by Country (2020-2031)

Figure 36. Germany Capillary Blood Lancing Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. France Capillary Blood Lancing Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. U.K. Capillary Blood Lancing Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Italy Capillary Blood Lancing Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Russia Capillary Blood Lancing Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Asia Pacific Capillary Blood Lancing Device Sales Market Share by Region (2020-2031)

Figure 42. Asia Pacific Capillary Blood Lancing Device Revenue Market Share by Region (2020-2031)

Figure 43. China Capillary Blood Lancing Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Japan Capillary Blood Lancing Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. South Korea Capillary Blood Lancing Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. India Capillary Blood Lancing Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Australia Capillary Blood Lancing Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. China Taiwan Capillary Blood Lancing Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Southeast Asia Capillary Blood Lancing Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Latin America Capillary Blood Lancing Device Sales Market Share by Country (2020-2031)

Figure 51. Latin America Capillary Blood Lancing Device Revenue Market Share by Country (2020-2031)

Figure 52. Mexico Capillary Blood Lancing Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Brazil Capillary Blood Lancing Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. Argentina Capillary Blood Lancing Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 55. Colombia Capillary Blood Lancing Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 56. Middle East and Africa Capillary Blood Lancing Device Sales Market Share by Country (2020-2031)

Figure 57. Middle East and Africa Capillary Blood Lancing Device Revenue Market Share by Country (2020-2031)

Figure 58. Turkey Capillary Blood Lancing Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 59. Saudi Arabia Capillary Blood Lancing Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 60. UAE Capillary Blood Lancing Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 61. Global Sales Market Share of Capillary Blood Lancing Device by Type (2020-2031)

Figure 62. Global Revenue Market Share of Capillary Blood Lancing Device by Type (2020-2031)

Figure 63. Global Capillary Blood Lancing Device Price (US$/Unit) by Type (2020-2031)

Figure 64. Global Sales Market Share of Capillary Blood Lancing Device by Application (2020-2031)

Figure 65. Global Revenue Market Share of Capillary Blood Lancing Device by Application (2020-2031)

Figure 66. Global Capillary Blood Lancing Device Price (US$/Unit) by Application (2020-2031)

Figure 67. Capillary Blood Lancing Device Value Chain

Figure 68. Channels of Distribution (Direct Vs Distribution)

Figure 69. Bottom-up and Top-down Approaches for This Report

Figure 70. Data Triangulation

Figure 71. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions